---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241103910.md"
description: "The Nasdaq Biotechnology Index rose by 1.55%. Among the constituent stocks, Akero Therapeutics increased by 22.71%, Sana Biotechnology rose by 22.02%, and 89bio climbed by 20.97%. COVID-19 vaccine concept stock CureVac NV ADR rose by 10.47%, while Moderna increased by 6.31%. In contrast, Anavex Life Sciences fell by 9.95%, Prime Medicine dropped by 15.01%, and Alumis decreased by 16.89%"
datetime: "2025-05-20T20:48:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241103910.md)
  - [en](https://longbridge.com/en/news/241103910.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241103910.md)
generator: "portal-rs"
---

# 

The Nasdaq Biotechnology Index closed up 1.55%. Component stock Akero Therapeutics rose 22.71%, Sana Biotechnology rose 22.02%, and 89bio rose 20.97%, ranking third. COVID-19 vaccine concept stocks CureVac NV ADR rose 10.47% and Moderna rose 6.31%, performing well. Anavex Life Sciences fell 9.95%, ranking third from the bottom, Prime Medicine fell 15.01%, and Alumis fell 16.89%

### Related Stocks

- [CVAC.US](https://longbridge.com/en/quote/CVAC.US.md)
- [AKRO.US](https://longbridge.com/en/quote/AKRO.US.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [SANA.US](https://longbridge.com/en/quote/SANA.US.md)
- [ETNB.US](https://longbridge.com/en/quote/ETNB.US.md)
- [AVXL.US](https://longbridge.com/en/quote/AVXL.US.md)
- [PRME.US](https://longbridge.com/en/quote/PRME.US.md)
- [ALMS.US](https://longbridge.com/en/quote/ALMS.US.md)

## Related News & Research

- [Immunovant Q1 2027 Earnings Call: Complete Transcript](https://longbridge.com/en/news/299320022.md)
- [SANA: IND and phase I/II trial for diabetes therapy and first-in-human CAR T data expected within 12 months](https://longbridge.com/en/news/299077912.md)
- [Moderna CFO James M. Mock disposes of 34,836 common shares worth $4.68 million](https://longbridge.com/en/news/298959314.md)
- [MRNA: Phase III melanoma success fuels expansion into new cancers, with scalable manufacturing and a strong vaccine portfolio](https://longbridge.com/en/news/298941796.md)
- [Promising Biotech Stocks To Keep An Eye On - September 12th](https://longbridge.com/en/news/298811794.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**